ASCENT INDUSTRIES CORP Financials ASCENT INDUSTRIES CORP Canadian Securities Exchange
Equities
HERB
CA42704B1067
Pharmaceuticals
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.05 CAD | 0.00% |
|
-9.09% | 0.00% |
| 05-09 | Herbal Dispatch Inc. Announces Board Changes | CI |
| 04-30 | Herbal Dispatch Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Valuation
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 60.82 | 32.02 | 5.851 | 6.473 | 3.668 | 3.681 |
| Enterprise Value (EV) 1 | 64.74 | 27.7 | 6.154 | 2.376 | 3.396 | 5.078 |
| P/E ratio | -2.03 x | -1.43 x | -0.84 x | -2.53 x | -0.54 x | -1.7 x |
| Yield | - | - | - | - | - | - |
| Capitalization / Revenue | 22.6 x | 43 x | 291 x | 9.46 x | 11.5 x | 0.78 x |
| EV / Revenue | 24.1 x | 37.2 x | 306 x | 3.47 x | 10.7 x | 1.07 x |
| EV / EBITDA | -3.16 x | -2.72 x | -1.87 x | -0.76 x | -1.27 x | -3.92 x |
| EV / FCF | -5.08 x | -11.4 x | -2.51 x | -1.59 x | -5.28 x | -15.6 x |
| FCF Yield | -19.7% | -8.8% | -39.9% | -63% | -18.9% | -6.39% |
| Price to Book | 1.7 x | 2.43 x | 0.69 x | 1 x | 0.58 x | 1.02 x |
| Nbr of stocks (in thousands) | 32,009 | 32,015 | 39,008 | 43,154 | 73,355 | 73,628 |
| Reference price 2 | 1.900 | 1.000 | 0.1500 | 0.1500 | 0.0500 | 0.0500 |
| Announcement Date | 11/05/20 | 11/05/20 | 21/04/21 | 12/04/22 | 28/04/23 | 30/04/24 |
1CAD in Million2CAD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net sales 1 | 2.688 | 0.744 | 0.0201 | 0.6842 | 0.3188 | 4.744 |
| EBITDA 1 | -20.46 | -10.18 | -3.284 | -3.118 | -2.673 | -1.294 |
| EBIT 1 | -23.36 | -10.97 | -4.098 | -3.682 | -2.9 | -1.685 |
| Operating Margin | -868.9% | -1,475.03% | -20,406.36% | -538.14% | -909.79% | -35.52% |
| Earnings before Tax (EBT) 1 | -30.49 | -22.39 | -6.435 | -2.381 | -4.578 | -2.071 |
| Net income 1 | -29.77 | -22.4 | -6.438 | -2.396 | -4.615 | -2.071 |
| Net margin | -1,107.63% | -3,010.1% | -32,061.99% | -350.13% | -1,447.78% | -43.66% |
| EPS 2 | -0.9368 | -0.6996 | -0.1780 | -0.0593 | -0.0923 | -0.0295 |
| Free Cash Flow 1 | -12.75 | -2.438 | -2.454 | -1.498 | -0.6429 | -0.3247 |
| FCF margin | -474.47% | -327.73% | -12,219.52% | -218.98% | -201.7% | -6.84% |
| FCF Conversion (EBITDA) | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 11/05/20 | 11/05/20 | 21/04/21 | 12/04/22 | 28/04/23 | 30/04/24 |
1CAD in Million2CAD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net Debt 1 | 3.93 | - | 0.3 | - | - | 1.4 |
| Net Cash position 1 | - | 4.32 | - | 4.1 | 0.27 | - |
| Leverage (Debt/EBITDA) | -0.1919 x | - | -0.0922 x | - | - | -1.079 x |
| Free Cash Flow 1 | -12.8 | -2.44 | -2.45 | -1.5 | -0.64 | -0.32 |
| ROE (net income / shareholders' equity) | -83.8% | -91.6% | -59.5% | -32.1% | -72.3% | -39.4% |
| ROA (Net income/ Total Assets) | -29.7% | -22.5% | -20.3% | -24.5% | -23.9% | -13.1% |
| Assets 1 | 100.2 | 99.44 | 31.69 | 9.786 | 19.34 | 15.86 |
| Book Value Per Share 2 | 1.120 | 0.4100 | 0.2200 | 0.1500 | 0.0900 | 0.0500 |
| Cash Flow per Share 2 | 0.0400 | 0.1200 | 0.0500 | 0.0900 | 0.0200 | 0 |
| Capex 1 | 21.6 | - | 0.09 | 0.08 | 0.03 | 0.01 |
| Capex / Sales | 802.08% | - | 430.8% | 12.07% | 10.42% | 0.13% |
| Announcement Date | 11/05/20 | 11/05/20 | 21/04/21 | 12/04/22 | 28/04/23 | 30/04/24 |
1CAD in Million2CAD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| +40.09% | 6.16B | |
| -16.34% | 4.46B | |
| -7.11% | 3.27B | |
| +5.14% | 3.2B | |
| -0.18% | 2.6B | |
| +47.93% | 1.98B | |
| -7.15% | 1.7B | |
| +0.67% | 1.66B | |
| -8.73% | 1.61B |
- Stock Market
- Equities
- HERB Stock
- HERB Stock
- Financials ASCENT INDUSTRIES CORP
